Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
EXACT Study: A Blinded Study in Patients With Alport Syndrome to Evaluate Exaluren Efficacy and SafetyCollagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Abnormalities, Urogenital Diseases, X-linked Alport syndrome, autosomal recessive Alport syndrome, connective tissue disorder, hereditary nephritis, kidney disorder, nephritis, urinary system disorderRecruitingPhase 22026-09-30NCT07523581

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Eloxx Pharmaceuticals, Inc.1

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Alder Hey Children's NHS Foundation TrustLiverpoolUnited Kingdom4
Denver Nephrologists PC, Colorado Kidney Care PCDenverUnited States1
Great Ormond Street HospitalLondonUnited Kingdom38
Hackensack University Medical CenterHackensackUnited States308
Renal Associates, P.A.San AntonioUnited States1
Royal Free HospitalLondonUnited Kingdom52
Royal Manchester Children's HospitalManchesterUnited Kingdom32
Stanford UniversityStanfordUnited States213
University of California, Los AngelesLos AngelesUnited States142
University of MinnesotaMinneapolisUnited States325
University of PennsylvaniaPhiladelphiaUnited States507